Novo Growth Equity Staffs Up
Scott Beardsley and Michael Shalmi have been named Copenhagen-based senior partners with Novo Growth Equity, a new Novo AS affiliate that is expecting to invest $200 million per year (first deal to come in six months). Beardsley previously ran JPMorgan's West Coast pharma practice out of San Francisco, while Shalmi was in New York as corporate VP of global development and clinical operations. Christina Sylvester-Hvid has also joined Novo Growth Equity as a principal, after having been a partner with Wiborg Biotech Consulting.
25 June 2009•3 mins read
